New leader spotlight, by VIDA. With Voptica CEO & Co-Founder Pablo Artal. The future of Ophthalmology.
https://vida-cs.com/blog/leader-in-the-spotlight-pablo-artal/
https://vida-cs.com/blog/leader-in-the-spotlight-pablo-artal/
Voptica will announce the first and only inverted meniscus intraocular lens (ArtIOLs) to improve peripheral vision at the 2021 ESCRS Satellite Symposium in Amsterdam on
🧨BREAKING NEWS FOR #ArtIOLs® IOLs🧨 NEW PARTNERSHIP IN GERMANY 🇩🇪We are pleased to announce that VOPTICA has recently partnered with OPHTEC Germany to distribute #ArtIOLs®
Intraocular lenses (IOLs) designs are constantly evolving to improve patients’ vision needs. Trifocal diffractive IOLs are designed to achieve good visual acuity at all distances,
Por medio de la presente, en virtud de acuerdo del Consejo de Administración de fecha 24de mayo de 2024, se convoca a los socios de
Recent publication in the prestigious American Journal of Ophthalmology about: “Peripheral Vision in Patients Following Intraocular Lens Implantation: A Systematic Review and Meta-Analysis.” Do not
🧨Breaking news in the IOL technology!🧨 #ArtIOLs Pablo Artal , founder, and CEO of VOPTICA will be lecturing about the super aspheric inverted meniscus IOLs,
La scorsa settimana abbiamo presentato al nostro distributore HealthTec srl le lenti intraoculari #ArtIOLs® 🇮🇹👀 Delighted to have through HealthTec srl booth many Italian #Ophthalmologists and
Before the weekend starts 👀 🙌 #ESCRS #WINTER Do #NOT miss what our clinical specialist Consuelo Robles García , PhD has prepared for The European
Por medio de la presente, se convoca a los socios de la mercantil VOPTICA, S.L. (en adelante, “Voptica” o la “Sociedad”), a la reunión de
VOPTICA team is delighted to be assisting for another year to the prestigious ESCRS show in Milano to present the latest company innovations and scientific